Home > Insider Trading > Filing (0001181431-11-050247)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1293973	B Christopher Ehrlich	C/O Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd, Suite 110 Point Richmond CA 94804		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-20	514,848	$6.59	1,766,656	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2011-09-21	217,228	$7.24	1,983,884	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $5.64 to $7.00 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
The reported securities are owned directly by InterWest Partners IX, L.P. ("the LP") and may be deemed to be beneficially owned indirectly by InterWest Management Partners IX, LLC ("the LLC"), as general partner of the LP. The reporting person as a venture member of the LLC disclaims any beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $6.96 to $7.50 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.